Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentostatin and DLI for Low Donor T-cell Chimerism After HCT
NCT00096161Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- May 2003
- Primary completion
- Feb 2015
- Modality
- Cell Therapies, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 2 trial of pentostatin, donor lymphocyte infusion in graft rejection, sponsored by Fred Hutchinson Cancer Center. Started May 2003; status: completed.
02
Drugs
pentostatindonor lymphocyte infusion
03
Conditions
graft rejection
Beyond the preview
Go deeper on NCT00096161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00096161.